Evidence map›Paper›PMID 32637391›Full record

ArticleFrontiers in chemistry2020

Quantum-Chemistry Based Design of Halobenzene Derivatives With Augmented Affinities for the HIV-1 Viral G

Perla El Darazi, Léa El Khoury, Krystel El Hage, Richard G Maroun, Zeina Hobaika, Jean-Philip Piquemal, Nohad Gresh

Open access · goldAbstract read
In one paragraph

Article in Frontiers in chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Perla El DaraziSorbonne Université, Laboratoire de Chimie Théorique, UMR7616 CNRS, Paris, France.
Léa El KhourySorbonne Université, Laboratoire de Chimie Théorique, UMR7616 CNRS, Paris, France.
Krystel El HageSABNP, Univ. Evry, INSERM U1204, Université Paris-Saclay, Evry, France.
Richard G MarounUR EGP, Centre d'Analyses et de Recherche, Faculté des Sciences, Université Saint-Joseph de Beyrouth, Beirut, Lebanon.
Zeina HobaikaUR EGP, Centre d'Analyses et de Recherche, Faculté des Sciences, Université Saint-Joseph de Beyrouth, Beirut, Lebanon.
Jean-Philip PiquemalSorbonne Université, Laboratoire de Chimie Théorique, UMR7616 CNRS, Paris, France.
Nohad GreshSorbonne Université, Laboratoire de Chimie Théorique, UMR7616 CNRS, Paris, France.
Saint Joseph University · LBSorbonne Université · FRCentre National de la Recherche Scientifique · FRUniversité Paris-Saclay · FRUniversity of California, Irvine · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The HIV-1 integrase (IN) is a major target for the design of novel anti-HIV inhibitors. Among these, three inhibitors which embody a halobenzene ring derivative (HR) in their structures are presently used in clinics. High-resolution X-ray crystallography of the complexes of the IN-viral DNA transient complex bound to each of the three inhibitors showed in all cases the HR ring to interact within a confined zone of the viral DNA, limited to the highly conserved 5'CpA 3'/5'TpG 3' step. The extension of its extracyclic CX bond is electron-depleted, owing to the existence of the "sigma-hole." It interacts favorably with the electron-rich rings of base G

Indexed as

DolutegravirHIV-1 integraseINSTIspolarizable force fieldsquantum chemistryviral DNA

Identifiers

PMID32637391
PMCPMC7317088
OpenAlexW2990027256

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.